arrow
Return

Penile calciphylaxis: A retrospective case-control study

delete2021-11-01
delete0
PRE
AI
C
Colleen K. Gabel
T
Teja Chakrala
R
Radhika Shah
M
Melissa Danesh
A
Allison S. Dobry
A
Anna Cristina Garza‐Mayers
L
Lauren N. Ko
E
Emily Nguyen
J
Jessica St. John
A
Andrew F. Walls
S
Sagar U. Nigwekar
P
Philip Song
D
Daniela Kroshinsky *
DOI:10.1016/j.jaad.2020.05.042delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Background: Calciphylaxis is a rare disorder characterized by skin necrosis caused by calcium deposition within vessels, thrombosis, and subsequent tissue ischemia. Penile involvement may rarely occur. Objective: To identify risk factors, diagnosis, management, and mortality of patients with penile calciphylaxis. Methods: A retrospective medical record review was conducted of 16 patients with penile calciphylaxis treated at 2 large urban tertiary care centers between January 2001 and December 2019. A control group of 44 male patients with nonpenile calciphylaxis at the same institution was included. Results: The median survival of patients with penile calciphylaxis was 3.8 months (interquartile range, 27.0 months). Mortality was 50% at 3 months and 62.5% at 6 months for penile calciphylaxis, and 13.6% at 3 months and 29.5% at 6 months for controls (P = .008). Patients with penile calciphylaxis were less likely to be obese (P = .04) but more likely to have hyperparathyroidism (P = .0003) and end-stage renal disease (P = .049). Limitations: Retrospective study design and small sample size. Conclusions: This study further defines the disease course of penile calciphylaxis, which has high mortality. Imaging may be used to aid diagnosis. Risk factors include end-stage renal disease, hyperparathyroidism, and normal body mass index.
Keywords:
calciphylaxis
diagnosis
management
outcomes
penile
risk factors
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Journal of the American Academy of Dermatology cover
Journal of the American Academy of Dermatology
IF:
11.8
Papers:
2.6W
Citations:
3.9W

Organization

M
Massachusetts General Hospital
Scholars:
3.4W
Papers: 2.6W
Citations: 8.6W
H
Harvard University
Scholars:
26.2W
Papers: 21.9W
Citations: 28.7W
R
rutgers university new brunswick
Scholars:
2.3W
Papers: 1.9W
Citations: 32
R
rutgers university system
Scholars:
4.1W
Papers: 3.6W
Citations: 53
R
rutgers university biomedical & health sciences
Scholars:
6.3K
Papers: 5.0K
Citations: 7
University of California System cover
University of California System
Scholars:
37.2W
Papers: 33.6W
Citations: 6.6K
H
Harvard Medical School
Scholars:
6.5W
Papers: 4.8W
Citations: 91
U
university of california irvine
Scholars:
2.2W
Papers: 1.7W
Citations: 55
researcher View more organizations